Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S S Legha

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Journal of the National Cancer Institute|February 15, 1995
Re: Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2S S Legha
Annals of Internal Medicine|August 1, 1988
Tamoxifen in the treatment of breast cancerS S Legha
Seminars in Oncology|February 1, 1997
The role of interferon alfa in the treatment of metastatic melanomaS S Legha
Annals of Internal Medicine|July 1, 1994
Are protected environments necessary for recipients of bone marrow transplants?S S Legha
Cancer|April 15, 1986
Interferons in the treatment of malignant melanoma. A review of recent trialsS S Legha
Annals of Internal Medicine|April 1, 1978
Tamoxifen for breast cancerS S Legha
Medical Toxicology|November 1, 1986
Vincristine neurotoxicity. Pathophysiology and managementS S Legha
Clinical Therapeutics|January 1, 1985
A review of mitomycin regimens in advanced breast cancer therapyS S Legha
The New England Journal of Medicine|May 18, 1995
Idiopathic dilated cardiomyopathyS S Legha
Seminars in Oncology|February 1, 1989
Current therapy for malignant melanomaS S Legha
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Journal of the National Cancer Institute|February 15, 1995
Re: Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2S S Legha
Annals of Internal Medicine|August 1, 1988
Tamoxifen in the treatment of breast cancerS S Legha
Seminars in Oncology|February 1, 1997
The role of interferon alfa in the treatment of metastatic melanomaS S Legha
Annals of Internal Medicine|July 1, 1994
Are protected environments necessary for recipients of bone marrow transplants?S S Legha
Cancer|April 15, 1986
Interferons in the treatment of malignant melanoma. A review of recent trialsS S Legha
Annals of Internal Medicine|April 1, 1978
Tamoxifen for breast cancerS S Legha
Medical Toxicology|November 1, 1986
Vincristine neurotoxicity. Pathophysiology and managementS S Legha
Clinical Therapeutics|January 1, 1985
A review of mitomycin regimens in advanced breast cancer therapyS S Legha
The New England Journal of Medicine|May 18, 1995
Idiopathic dilated cardiomyopathyS S Legha
Seminars in Oncology|February 1, 1989
Current therapy for malignant melanomaS S Legha
Pageof 15